Oceanside, CA, United States of America

Ken Curry

USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ken Curry - Innovator in Ocular Drug Delivery

Introduction

Ken Curry is a notable inventor based in Oceanside, California. He has made significant contributions to the field of ocular medicine through his innovative patent. His work focuses on improving drug delivery methods for treating ocular disorders.

Latest Patents

Ken Curry holds a patent for a drug-eluting ocular implant. This invention involves drug delivery devices and methods designed for the treatment of ocular disorders that require targeted and controlled administration of medication to the interior of the eye. The devices are engineered for the controlled release of one or more drugs and may include structures that facilitate the treatment of increased intraocular pressure by allowing aqueous humor to flow out of the anterior chamber of the eye through the device.

Career Highlights

Ken Curry is associated with Dose Medical Corporation, where he applies his expertise in developing advanced medical devices. His innovative approach has the potential to significantly enhance the quality of life for patients suffering from ocular disorders.

Collaborations

Ken has collaborated with notable professionals in his field, including David S. Haffner and Harold Alexander Heitzmann. These collaborations have contributed to the advancement of his research and the development of effective medical solutions.

Conclusion

Ken Curry's work in ocular drug delivery represents a significant advancement in medical technology. His innovative patent and collaboration with esteemed colleagues highlight his commitment to improving patient care in the field of ophthalmology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…